ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,212,000 | +71.2% | 26,216 | -10.1% | 0.00% | +50.0% |
| Q1 2019 | $708,000 | +100.6% | 29,160 | +13.4% | 0.00% | +100.0% |
| Q4 2018 | $353,000 | +4.7% | 25,717 | +16.0% | 0.00% | 0.0% |
| Q3 2018 | $337,000 | -9.4% | 22,164 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $372,000 | -9.5% | 22,164 | -11.9% | 0.00% | 0.0% |
| Q1 2018 | $411,000 | +28.0% | 25,148 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $321,000 | +48.6% | 25,148 | +42.1% | 0.00% | 0.0% |
| Q3 2017 | $216,000 | +45.9% | 17,700 | 0.0% | 0.00% | – |
| Q2 2017 | $148,000 | -6.3% | 17,700 | 0.0% | 0.00% | – |
| Q1 2017 | $158,000 | +79.5% | 17,700 | +77.0% | 0.00% | – |
| Q4 2016 | $88,000 | -34.3% | 10,000 | -50.0% | 0.00% | – |
| Q3 2016 | $134,000 | +282.9% | 20,000 | +100.0% | 0.00% | – |
| Q2 2016 | $35,000 | +20.7% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $29,000 | -31.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2015 | $42,000 | -8.7% | 10,000 | 0.0% | 0.00% | – |
| Q3 2015 | $46,000 | -36.1% | 10,000 | 0.0% | 0.00% | – |
| Q2 2015 | $72,000 | -1.4% | 10,000 | 0.0% | 0.00% | – |
| Q1 2015 | $73,000 | +55.3% | 10,000 | 0.0% | 0.00% | – |
| Q4 2014 | $47,000 | +30.6% | 10,000 | 0.0% | 0.00% | – |
| Q3 2014 | $36,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2014 | $45,000 | -4.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2014 | $47,000 | -6.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2013 | $50,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |